those treated at low-volume hospitals. 3, 4 A potential mechanism of the volume-outcome relationship is that hospitals with greater case volumes are likely to be equipped with skilled resources and advanced medical infrastructure, thereby providing optimal treatment and care; consequently, their patients obtain better treatment outcomes. 5 Hospital volumes have been measured according to various definitions, including the number of patients who were diagnosed, received treatment [5] [6] [7] [8] or underwent surgeries. 4 Surgical procedure volume is a commonly used measurement to assess the volumeoutcome relationship. 4 To date, there is no gold standard for the thresholds of hospital volume. As an alternative, studies have categorized hospital volume by percentiles, [9] [10] [11] [12] clinically relevant cutoffs 13, 14 or convenient cutoffs. [15] [16] [17] This heterogeneity of surgical volume measurements may affect the external validity of study results. 4 Patient outcomes used in previous studies have also varied; these include 5-year survival, 7, 18 postoperative mortality, 19, 20 procedure-related complications 11, 21 and recurrence of cancer. 16, 22 Although a number of studies have demonstrated that patients treated at high-volume hospitals have better outcomes, patient characteristics are critical confounders to the choice of hospital and patient outcomes. 23, 24 In addition, the variation of volume-outcome relationships may be affected by the clinical rarity and technical complexity of the surgical procedure. For instance, rare, complex cancer operations have stronger associations with mortality than common and simple operations. 25 Although the strength of the association between hospital volume and mortality varies according to the type of surgery, 25 some countries have applied the evidence of volume-outcome relationships to quality and safety control programs. For instance, state authorities or professional societies in European and North American countries assess whether hospitals meet minimum volume standards for pancreatic, esophageal, lung, hepatic or biliary tract resections, and levy penalties or offer interventions to noncompliant hospitals. 26 In the United States, the National Cancer Policy Board recommends surgery volume as a quality indicator, 3, 27 and a non-profit organization conducts hospital surveys and presents the achievement status of minimal surgical volume to individual hospitals. 28 In Japan, a minimum hospital volume standard is used as an eligibility criterion for designated cancer care hospitals, and as an indicator to monitor their performance. 29 The majority of studies on the volume-outcome relationship previously conducted in Japan focused on a single cancer site. 21, [30] [31] [32] [33] [34] [35] One study reported the volume-survival relationship for multiple sites of cancer diagnosed in 1994-1998; hospital volume was defined by the number of patients treated. 7 Since then, Osaka has changed in terms of its population structure, medical technology and cancer control policy, and has improved its cancer registry system. Moreover, patients undergo surgeries or non-surgical treatments in real-world settings. Surgical indications are influenced by the preoperative functional ability and are predictive of prognosis. Therefore, focusing on surgical cases is likely to illustrate the volume-outcome association more clearly than cases undergoing treatment by all modalities. Updated evidence in a sample of patients undergoing surgeries is therefore needed. This study examined the association between surgery-based hospital procedure volumes and survival of cancer patients between 2007 and 2011.
| MATERIAL S AND ME THODS

| Study design, setting and data source retrieved
This retrospective cohort study used individual data of cancer patients from the Osaka Cancer Registry (OCR). The OCR is a population-based longitudinal database that registers all cancer cases and follows up their vital status in Osaka Prefecture, Japan. An estimated population of 8.9 million resided in Osaka according to the 2010 census. 36 fixed across medical facilities. 37 The OCR updates the vital status of all registered cases at 3, 5 and 10 years from diagnosis. The proportion of incident cases in the database notified only by death certificates in 2011 was 8.7%, and the incidence/mortality ratio was 2.24. 38
| Study sample
Cancer cases of the following five sites were analyzed: stomach (C16 in ICD-10), colorectum (C18, C19, and C20), lung (C33 and C34), breast (C50) and uterus (C53, C54 and C55). We selected these cancer sites as they accounted for 55.5% of the overall cancer incidence during the study period. The study sample met the following criteria: diagnosed with cancer between 2007 and 2011, lived in Osaka at the time of diagnosis, aged 15-99 years at diagnosis, and had undergone surgery at hospitals in Osaka. We excluded those who underwent surgery at clinics or those whose deaths were exclusively notified by death certificates. The remainder were included in the study sample for generating variables for hospital volume. For survival analysis, we excluded those aged 85-99 years as older age is a critical confounder to the choice of hospital 23, 24 and survival probability. Male breast cancer cases and cases where there was a lack of information regarding the survival status at 5 years from diagnosis or the survival period between the diagnosis and the last observation were excluded from the analysis ( Figure 1 ).
| Potential confounders
The following variables were used as potential confounders:
year of diagnosis (2007, 2008, 2009, 2010 and 2011) , sex (men and women), age group (15-54, 55-64, 65-74 and 75-84), stage of cancer (localized [cancer remained in the initial organ], regional [cancer spread to regional lymph nodes or adjacent tissues], distant [cancer spread to distant organs] and unknown), extent of resection of primary tumor (all, partial and unknown), receipt of adjuvant therapy (received, not received and unknown), receipt of radiation therapy (received, not received and unknown) and residential area (eight divisions according to the prefectural medical administration system).
| Study outcome
The primary outcome of this study was the 5-year survival from the time of cancer diagnosis. We terminated observations on the date of death that might have occurred any time within 5 years from diagnosis or were censored at 5 years from diagnosis, if participants survived.
F I G U R E 1 Flowchart of the study sample selection
| Categorization of hospital volume
We defined hospital volume as the annual average volume of sur- 
| Statistical analysis
First, we calculated the number of hospitals, mean and the range of annual surgery volume, and the number of patients for each hospital volume category. We compared the distribution of the basic characteristics of the study sample among the five selected cancer sites. We then estimated the mortality hazard ratios of hospital volumes using the Cox proportional hazard regression model.
In the model, we controlled potential confounders, including the year of diagnosis, sex, age group, cancer stage, extent of resection of primary tumor, receipt of adjuvant therapy, receipt of radiation therapy and residential area. We adjusted the confidence intervals of the hazard ratio using robust estimators of variance as the study sample within the same hospital would have cluster correlations. Finally, we estimated adjusted survival rates based on multivariable Cox proportional hazard regression. To provide further supporting information, we examined factors associated with surgery at very low-volume hospitals (1 = very low-volume hospitals, 0 = high-volume, medium-volume and low-volume hospitals) using multivariable logistic regression. We defined statistical significance as a P-value of <0.05. The Stata 14.2 statistical software package was used for all analyses (Stata).
| Ethical considerations
We obtained ethical approval from the Institutional Review Board of Osaka International Cancer Institute (approval number: 18-0018) before initiating the study. The data had been anonymized before use.
| RE SULTS
We identified 144 941 cases diagnosed with cancer at any of the five selected sites between 2007 and 2011, selected 86 145 cases for generating categorical variables for hospital volume, and identified 80 959 cases for survival analysis (Figure 1 Table S6 . Patients who were male, of older age and had regional/distant stages of cancer at diagnosis (except colorectal and uterine cancers) were more likely to undergo surgery at very low-volume hospitals (Table S7 ). 
| D ISCUSS I ON
Patients treated at very low-volume hospitals showed a significantly higher mortality hazard than those treated at high-volume hospitals across the five selected sites of cancer. However, the strength of the volume-survival relationship varied with the cancer site. The differences in survival probability between very low-volume and low-volume hospitals were greater than those among low-volume, medium-volume and high-volume hospitals. Overall, the results were consistent with those of a previous study conducted at the same study site. 7 Factors associated with undergoing surgery at very low-volume hospitals were male gender, older age and regional/distant stage at cancer diagnosis. This suggests that volume standards should be formulated based on country-specific characteristics, such as the burden of cancer and healthcare systems.
Moreover, the plots of adjusted survival rates per hospital volume category showed a wider interval between very low-volume and low-volume hospitals, whereas narrower intervals were observed among low-volume, medium-volume and high-volume hospitals. The findings have two implications. First, a hospital with a lack of surgical experience may negatively affect patient survival. This supports the idea that applying a minimum hospital volume standard, is advantageous. Second, patient survival may not be affected by the hospital volume if hospitals perform a greater number of surgical procedures than the minimum volume threshold. Because the site of the study was an urban area with the third largest population in the country, the hospitals with low-volume or medium-volume may have had frequent opportunities to perform surgeries 32, 33 Note: Adjusted hazard ratios were controlled for year of diagnosis, sex, age group, cancer stage, extent of resection of primary tumor, adjuvant therapy received, radiation therapy received and residential area (The full result is reported in Table S6 ).
Abbreviations: CI, confidence interval; High, high-volume hospitals; HR, hazard ratio; Low, low-volume hospitals; Medium, medium-volume hospitals; Very low, very low-volume hospitals.
F I G U R E 2
Adjusted 5-y survival rates per hospital volume category based on post-estimations of multivariable Cox proportional hazard regression. High, high-volume hospitals; Low, low-volume hospitals; Medium, medium-volume hospitals; Very low, very low-volume hospitals no role in the design of the study, in the analysis and interpretation of the data, or in the preparation, review or approval of the manuscript.
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